Education
About Us
Working with TipRanks
Follow Us
Palatin Technologies (PTNT)
OTHER OTC:PTNT
Tirzepatide, Bremelanotide
Obesity
Phase II
Active Not Recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Jun 05, 2024
―
Pl8177
Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare
Phase II
Active Not Recruiting
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
May 25, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Palatin Technologies (PTNT) have in its pipeline
PTNT is currently developing the following drugs: Tirzepatide, Bremelanotide, Pl8177. These drug candidates are in various stages of clinical development as the company works toward FDA approval.